Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Employers to drop GLP-1 weight loss drug coverage in 2027 Takeaway: Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from lower prices for Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo
1 Can I take Mounjaro if I have high cholesterol but a healthy BMI
Retatrutide Phase 2 trial New England Journal of Medicine Peer-reviewed Phase 2 trial data on retatrutide in adults with obesity
Lifestyle factors play an equally important role: A calorie-controlled, nutritious diet amplifies the appetite-suppressing effects of the medication
In November 2025, a separate letter flagged manufacturing issues at a contract facility producing semaglutide
US$ 22.71
US$ 26.90
US$ 23.84
US$ 27.62
US$ 22.61
US$ 26.18
US$ 29.08
US$ 27.30
US$ 28.22
